Supplemental Figure 1.
(A) AJP001-DPP4-1 epitope conjugated vaccine was administered intracutaneously to BALB/cA mice at a dose of 100 μg per mouse three times at two-week intervals (n=6). (B) AJP001-DPP4-2,3,4 epitope conjugated vaccines were administered intracutaneously to BALB/cA mice at a dose of 250 μg per mouse at 0, 2 and 4 weeks and boosted at 9 weeks (n=8). (C) AJP001-Ang II was administered intracutaneously to Dahl rats at a dose of 500 or 1000 μg per rat at 0, 2 and 4 weeks (n=3). The anti-DPP4 IgG antibody titer in serum samples was measured by ELISA. The titers are expressed as the dilution fold of the serum giving half-maximal absorbance at 450 nm. All data are expressed as the mean ± SD. 
